FAM3A encodes a secreted protein with a GG domain, which is a characteristic feature of the FAM3 family. The GG domain is involved in protein-protein interactions and is essential for the protein’s function. FAM3A is known to play a role in the regulation of glucose and lipid metabolism, making it a significant protein in the context of metabolic diseases.
The protein is ubiquitously expressed in various tissues, indicating its importance in multiple physiological processes. It has been observed that changes in the expression of FAM3A can have significant implications for cellular function and overall health.
Alterations in the expression of FAM3A have been linked to several diseases. For instance, it has been associated with metabolic disorders such as diabetes and obesity. The protein’s role in regulating glucose and lipid metabolism makes it a potential target for therapeutic interventions aimed at treating these conditions.
Additionally, FAM3A has been implicated in cancer biology. Changes in its expression have been noted in pancreatic cancer-derived cells, suggesting that it may play a role in tumorigenesis. Further research is needed to fully understand the mechanisms by which FAM3A contributes to cancer development and progression.
Recombinant FAM3A protein is widely used in research to study its function and role in various diseases. The recombinant protein is typically produced in an expression system such as E. coli and purified to high levels of purity. This allows researchers to conduct experiments to elucidate the protein’s function, interactions, and potential as a therapeutic target.